WFE Implant & Doping Equipment

Ion implantation equipment is the narrowest vendor category in wafer fab equipment. The commercial market is effectively a duopoly between Applied Materials (VIISta platform family, Varian legacy products — approximately 60% market share) and Axcelis Technologies (Purion platform family — approximately 40% market share). No third credible vendor operates at leading-node scale. The small set of specialty and Chinese domestic players (Beijing Zhongke Xinyuan, CETC) serve mature-node and specialty applications and have not closed the capability gap at advanced nodes. This concentrated vendor structure makes the category simpler to map than deposition or etch but equally strategic — every chip requires multiple implant steps, and the Applied-Axcelis duopoly is effectively non-substitutable for modern logic and memory production.

This page covers ion implantation through the equipment and vendor lens — implanter types, vendor market positions, tool family taxonomies, and the alternative doping pathways (plasma doping, in-situ epitaxial doping) that are reshaping the category at advanced nodes. For the process-activity view — what ion implantation does physically, dopant species selection, junction formation, annealing — see Doping (process lens).

Ion Implanter Types by Dose and Energy

Commercial ion implanters are specialized by dose (ions per cm²) and energy (keV) regime. A modern fab operates multiple implanter classes because the doping requirements span from ultra-shallow source/drain extensions at sub-keV energies to deep well implants at MeV energies. Each regime has its own tool optimization.

Plasma doping (PLAD) is the most significant category evolution in recent years. Conventional beam-line implant delivers ions in a directed line-of-sight trajectory, which creates shadowing problems when the target is a 3D structure — a fin sidewall or nanosheet perimeter cannot be uniformly doped by a directed beam without rotation and tilt, and even then non-uniformities are hard to eliminate. Plasma doping creates a plasma sheath adjacent to the wafer and accelerates ions through the sheath in all directions, delivering conformal dose to 3D structures. PLAD has become essential at advanced FinFET and GAA nodes and at 3D NAND channel doping.

Vendor Landscape

The Axcelis Purion Platform Strategy

Axcelis's Purion platform architecture is a distinctive strategic choice that differentiates the company from Applied's portfolio approach. Where Applied operates multiple VIISta product lines optimized for specific implant classes (HP for high dose, HE for high energy, HCP for high current), Axcelis unified its entire product line around a single Purion chassis architecture. Each Purion variant (H, M, HT, VXE, XEmax, Dragon) shares common mechanics, control systems, and software with variant-specific beam delivery optimized for the target implant regime.

The Purion unified-platform approach delivers customer benefits that have driven Axcelis's market share gains over the past decade. Fabs running multiple implant classes can share parts inventory, operator training, maintenance protocols, and process knowledge across their entire implant bay when all tools are Purion-based. Process engineers developing implant recipes can migrate recipes across Purion variants with less requalification effort than between historical Applied VIISta generations. The unified-platform strategy has been particularly effective at memory fabs running high volume across multiple implant classes.

Applied has responded with tighter integration across VIISta variants and leveraging its broader WFE customer relationships, but Axcelis's growth at advanced nodes and specifically at SiC implant reflects the Purion platform's competitive strength. The competitive dynamic in implant is one of the cleaner head-to-head competitions in WFE — two vendors, distinctive strategies, concrete customer choice.

SiC Implant as Specialty

SiC power semiconductor fabrication requires different implant parameters from silicon fabrication — higher target temperatures during implant (500°C+ vs. room temperature for silicon), different dopant species optimization (aluminum and nitrogen rather than boron and phosphorus as primary dopants), and different anneal requirements (1700°C+ post-implant anneal vs. sub-1100°C for silicon). Conventional silicon implanters cannot be straightforwardly used for SiC without hardware modifications and process development.

Axcelis has specific SiC-optimized Purion products (Purion H SiC family) serving Wolfspeed, STMicro, Infineon, Onsemi, Bosch, and the other major SiC device manufacturers. This is a smaller market than silicon implant in unit terms but a growing one tied to the EV power electronics buildout documented on ElectronsX. Axcelis's early investment in SiC-specific implant capability has given it a strong position in this specialty category, comparable to its growing general market share against Applied.

The SiC implant specialty illustrates how equipment vendors respond to emerging substrate types. As GaN and other wide-bandgap semiconductor categories mature, equivalent implant specialty tools will emerge. The equipment lens on the wide-bandgap semiconductor supply chain includes not just the substrate fabs (Wolfspeed Mohawk Valley, STMicro Catania, Infineon Villach) but the implant tool supply that enables their production.

In-Situ Doping and Doping Alternatives

Not all doping happens via ion implantation. At advanced nodes, in-situ doping during epitaxial growth — introducing dopant species into the gas flow during silicon or SiGe epitaxy — has become important for source/drain doping in FinFET and GAA devices. In-situ doping creates a precisely graded dopant profile as the epitaxial layer grows, avoiding the lattice damage that ion implantation causes and eliminating the post-implant anneal step. The epitaxy tool (Applied Materials Centura Epi, ASM International Epsilon, TEL epi systems) effectively becomes a doping tool for these applications.

The implant vendor ecosystem has responded to this shift by expanding into molecular and cluster beam implant technologies that deliver multiple atoms per impact event (reducing implant damage per dose), and by integrating with epitaxy and thermal process equipment suppliers. The boundary between implant and adjacent process categories is less distinct than it was a decade ago — a trend the equipment lens captures that the process-activity lens does not.

Lead Times & Installation

Ion implanters have lead times comparable to deposition and etch — typically 9–15 months for mainstream platforms, extending toward 18 months for the most advanced configurations (ultra-low energy advanced-node tools, highest-throughput PLAD systems). Installation requires specialized infrastructure: ion implanters generate X-rays during operation that require shielded bays, use hazardous dopant species (arsine, phosphine, diborane) that require specialized gas handling and abatement, and operate with high-voltage beam line systems that require extensive safety interlocking. The hazardous gas handling infrastructure is often the secondary limiting factor for fab expansion rather than the tools themselves.

Export Controls

US BIS October 2022 rules restricted advanced ion implanter exports to Chinese leading-edge fab programs, with Applied Materials VIISta advanced-node tools and Axcelis Purion leading-edge variants both subject to licensing requirements. Japan's 2023 controls include Sumitomo Heavy Industries implant platforms. The Chinese domestic response has been underway for years but remains capability-limited at leading nodes — Beijing Zhongke Xinyuan and CETC serve mature-node Chinese fabs but have not qualified at advanced nodes. The practical effect has been to force Chinese fabs to rely on pre-restriction Applied and Axcelis installed base for any sub-28 nm implant capability, with no short-term domestic substitution path.

Related Coverage

Parent: Wafer Fab Equipment

Process-activity lens: Doping (same step, physics/process view)

Peer WFE categories: Deposition (in-situ epitaxial doping alternative) · Thermal Processing (post-implant anneal) · Lithography

Adjacent supply layers: Fab Consumables (dopant species gases: arsine, phosphine, diborane)